SCOPUS 정보 검색 플랫폼

Volumn 50, Issue 6, 2002, Pages 816-818

Anergy and chemokine receptors

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR;

CLONAL ANERGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; REVIEW;

CLONAL ANERGY; HIV INFECTIONS; HUMANS; RECEPTORS, CHEMOKINE;

EID: 0036598065 PISSN: 00045772 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (1)

References (12)

1
- 0030451267
- HIV and the transmembrane domain receptors
- Broder CC, Dimitrov DS. HIV and the transmembrane domain receptors. Pathobiol 1996;64:171-9.
- (1996) Pathobiol , vol.64 , pp. 171-179
- Broder, C.C.¹ Dimitrov, D.S.²

2
- 19244380883
- CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
- He J, Chen Y, Farzan M, et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997;385:645-9.
- (1997) Nature , vol.385 , pp. 645-649
- He, J.¹ Chen, Y.² Farzan, M.³

3
- 0031042433
- The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
- Bleui CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci 1997;94:1925-30.
- (1997) Proc Natl Acad Sci , vol.94 , pp. 1925-1930
- Bleui, C.C.¹ Wu, L.² Hoxie, J.A.³ Springer, T.A.⁴ Mackay, C.R.⁵

4
- 0031575431
- Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
- Connor RI, Sheridan KE, Ceradini D, Chose S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997;185:621-8.
- (1997) J Exp Med , vol.185 , pp. 621-628
- Connor, R.I.¹ Sheridan, K.E.² Ceradini, D.³ Chose, S.⁴ Landau, N.R.⁵

5
- 16044370087
- The CXC chemokine SDF-1 is the ligand for LESTR/fusion and prevents infection by T-cell-line-adapted HIV-1
- Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusion and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-5.
- (1996) Nature , vol.382 , pp. 833-835
- Oberlin, E.¹ Amara, A.² Bachelerie, F.³

6
- 0028875441
- Anergy, AIDS and Tuberculosis
- Hegde HR. Anergy, AIDS and Tuberculosis. Med Hypotheses 1995;45:433-40.
- (1995) Med Hypotheses , vol.45 , pp. 433-440
- Hegde, H.R.¹

7
- 0035032113
- Anergy and human immunodeficiency virus infection
- Hegde HR, Robbins SM. Anergy and human immunodeficiency virus infection. Med Hypotheses 2001;56:376-80.
- (2001) Med Hypotheses , vol.56 , pp. 376-380
- Hegde, H.R.¹ Robbins, S.M.²

8
- 0035093680
- Anergy and acquired immune deficiency syndrome
- Hegde HR, Woodman RC, Robbins SM. Anergy and acquired immune deficiency syndrome. Med Hypotheses 2001;56:250-5.
- (2001) Med Hypotheses , vol.56 , pp. 250-255
- Hegde, H.R.¹ Woodman, R.C.² Robbins, S.M.³

9
- 0027409391
- T-Cell dysfunction in HIV infection : Anergy due to defective antigen-presenting cell function
- Meyaard L, Shuitemaker H, Miedema R. T-Cell dysfunction in HIV infection : anergy due to defective antigen-presenting cell function. Immunol Today 1993;14:161-4.
- (1993) Immunol Today , vol.14 , pp. 161-164
- Meyaard, L.¹ Shuitemaker, H.² Miedema, R.³

10
- 0027692154
- Multifactorial nature of human immunodeficiency virus disease : Implications for therapy
- Fauci AS. Multifactorial nature of human immunodeficiency virus disease : Implications for therapy. Science 1993;262:1011-8.
- (1993) Science , vol.262 , pp. 1011-1018
- Fauci, A.S.¹

11
- 0030892234
- Apoptosis by death factor
- Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
- (1997) Cell , vol.88 , pp. 355-365
- Nagata, S.¹

12
- 0027340737
- Immunoglobulin VH3 gene products : Natural ligands for HIV gp 120
- Berberian L, Goodglick L, Kipps TJ, Bruan J. Immunoglobulin VH3 gene products : Natural ligands for HIV gp 120. Science 1993;261:1558-91.
- (1993) Science , vol.261 , pp. 1558-1591
- Berberian, L.¹ Goodglick, L.² Kipps, T.J.³ Bruan, J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.